All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-30640198

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30640198	A98G	RT	gag-pol	HIV Infections	D G L	View
2	30640198	D67G	RT	gag-pol	HIV Infections	D G L	View
3	30640198	D67N	RT	gag-pol	HIV Infections	D G L	View
4	30640198	E138A	RT	gag-pol	HIV Infections	D G L	View
5	30640198	E138G	RT	gag-pol	HIV Infections	D G L	View
6	30640198	E138K	RT	gag-pol	HIV Infections	D G L	View
7	30640198	E138Q	RT	gag-pol	HIV Infections	D G L	View
8	30640198	F227L	RT	gag-pol	HIV Infections	D G L	View
9	30640198	G190A	RT	gag-pol	HIV Infections	D G L	View
10	30640198	G190E	RT	gag-pol	HIV Infections	D G L	View
11	30640198	G190Q	RT	gag-pol	HIV Infections	D G L	View
12	30640198	G190R	RT	gag-pol	HIV Infections	D G L	View
13	30640198	G190S	RT	gag-pol	HIV Infections	D G L	View
14	30640198	I50L	PR	gag-pol	HIV Infections	D G L	View
15	30640198	K101E	RT	gag-pol	HIV Infections	D G L	View
16	30640198	K101H	RT	gag-pol	HIV Infections	D G L	View
17	30640198	K101N	RT	gag-pol	HIV Infections	D G L	View
18	30640198	K101Q	RT	gag-pol	HIV Infections	D G L	View
19	30640198	K103N	RT	gag-pol	HIV Infections	D G L	View
20	30640198	K103S	RT	gag-pol	HIV Infections	D G L	View
21	30640198	K219E	RT	gag-pol	HIV Infections	D G L	View
22	30640198	K219Q	RT	gag-pol	HIV Infections	D G L	View
23	30640198	K43T	PR	gag-pol	HIV Infections	D G L	View
24	30640198	K65R	RT	gag-pol	HIV Infections	D G L	View
25	30640198	K70R	RT	gag-pol	HIV Infections	D G L	View
26	30640198	K70T	RT	gag-pol	HIV Infections	D G L	View
27	30640198	L100I	RT	gag-pol	HIV Infections	D G L	View
28	30640198	L10F	PR	gag-pol	HIV Infections	D G L	View
29	30640198	L210W	RT	gag-pol	HIV Infections	D G L	View
30	30640198	L33F	PR	gag-pol	HIV Infections	D G L	View
31	30640198	L74I	RT	gag-pol	HIV Infections	D G L	View
32	30640198	L74V	RT	gag-pol	HIV Infections	D G L	View
33	30640198	M184V	RT	gag-pol	HIV Infections	D G L	View
34	30640198	M230L	RT	gag-pol	HIV Infections	D G L	View
35	30640198	M41L	PR	gag-pol	HIV Infections	D G L	View
36	30640198	M46I	PR	gag-pol	HIV Infections	D G L	View
37	30640198	P225H	PR	gag-pol	HIV Infections	D G L	View
38	30640198	Q58E	PR	gag-pol	HIV Infections	D G L	View
39	30640198	T215A	RT	gag-pol	HIV Infections	D G L	View
40	30640198	T215F	RT	gag-pol	HIV Infections	D G L	View
41	30640198	T215I	RT	gag-pol	HIV Infections	D G L	View
42	30640198	T215N	RT	gag-pol	HIV Infections	D G L	View
43	30640198	T215S	RT	gag-pol	HIV Infections	D G L	View
44	30640198	T215Y	RT	gag-pol	HIV Infections	D G L	View
45	30640198	V106A	RT	gag-pol	HIV Infections	D G L	View
46	30640198	V106I	RT	gag-pol	HIV Infections	D G L	View
47	30640198	V108I	RT	gag-pol	HIV Infections	D G L	View
48	30640198	Y115F	RT	gag-pol	HIV Infections	D G L	View
49	30640198	Y181C	RT	gag-pol	HIV Infections	D G L	View
50	30640198	Y181G	RT	gag-pol	HIV Infections	D G L	View
51	30640198	Y181V	RT	gag-pol	HIV Infections	D G L	View
52	30640198	Y188C	RT	gag-pol	HIV Infections	D G L	View
53	30640198	Y188F	RT	gag-pol	HIV Infections	D G L	View
54	30640198	Y188L	RT	gag-pol	HIV Infections	D G L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.